FDA Authorizes First Non-Prescription Home Coronavirus Test

FDA Authorizes First Non-Prescription Home Coronavirus Test

The test delivers results to your smartphone within 15 minutes of collecting a sample.

The FDA authorized the first coronavirus test that can be bought in a store without a prescription on December 15, says NPR.

The at-home test is made by the Australian company Ellume and will be available in January. It is administered using a swab and produces results within 15 minutes via a smartphone app. Collecting the sample for testing takes about five minutes.

“[The] authorization is a major milestone in diagnostic testing for COVID-19,” FDA Commissioner Stephan Hahn said.

The test will cost about $30 and can be used for both adults and children as young as 2-years-old.

About the Author

Nikki Johnson-Bolden is an Associate Content Editor for Occupational Health & Safety.

Product Showcase

  • SlateSafety BAND V2

    SlateSafety BAND V2

    SlateSafety's BAND V2 is the most rugged, easy-to-use connected safety wearable to help keep your workforce safe and help prevent heat stress. Worn on the upper arm, this smart PPE device works in tandem with the SlateSafety V2 system and the optional BEACON V2 environmental monitor. It includes comprehensive, enterprise-grade software that provides configurable alert thresholds, real-time alerts, data, and insights into your safety program's performance all while ensuring your data is secure and protected. Try it free for 30 days. 3

Featured

Webinars